Načítá se...
Minorities Are Underrepresented in Clinical Trials of Pharmaceutical Agents for Cystic Fibrosis
Rationale: Members of racial or ethnic minorities make up an appreciable proportion of patients with cystic fibrosis (CF) and have worse outcomes than non-Latino white individuals. Between 1,999 and 2014, the CF Foundation Patient Registry reported an increase in minorities from 5 to 8.2% for Latino...
Uloženo v:
| Vydáno v: | Ann Am Thorac Soc |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Thoracic Society
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5122490/ https://ncbi.nlm.nih.gov/pubmed/27410177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201603-192BC |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|